Curium Acquires Zevacor Molecular
March 3, 2020
Curium has acquired Zevacor Molecular, a producer of Strontium-82 used to make Rubidium-82 generators for cardiac PET imaging. The acquisition expands Curium's PET product capabilities and brings Zevacor's manufacturing infrastructure and employees into the Curium organization.
- Buyers
- Curium
- Targets
- Zevacor Molecular
- Industry
- Pharmaceuticals
- Location
- Indiana, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.